Pfizer’s Prevnar 20 with Pfizer-BioNTech COVID-19 vaccine shows positive results in phase-III study
responses elicited by Prevnar 20 for all 20 serotypes were similar whether given with a dose of the Pfizer-BioNTech COVID-19…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Covid 19 vaccine
Covaxin booster neutralises Omicron and Delta variants of SARS-CoV-2: Study
Hundred per cent of test serum samples showed neutralisation of the Delta variant and more than 90 per cent of serum samples…
S Korea authorises use of Novavax COVID-19 vaccine
South Korean vaccine developer SK Bioscience said it will produce the Novavax vaccine
J&J says single dose protects against breakthrough COVID-19 for up to six months
The study, sponsored by the vaccine developer, was conducted between 1st January and 7th September last year, before the Omicron…
Leiden University Medica Center and Intravacc to start clinical trial with new intranasal corona…
Nasal spray vaccine based on soluble nano-spheres with synthetic corona proteins
Interval between Moderna COVID-19 vaccine second shot and booster still six months: FDA
"Right now, if you got J&J, you get a booster after two months, if you got Pfizer as your primary series you can get a booster…
Researchers at Technical University of Munich investigate mRNA nanoparticles
Researchers at the Heinz Maier-Leibnitz Zentrum (MLZ) used the high neutron flux available in Garching to characterise various…
Biological E aims to produce 100 million doses/month of Corbevax from Feb 2022
Soon, the company plans to deliver more than one billion additional doses globally
Health ministry approves Corbevax, Covovax and Molnupiravir for restricted use in emergency…
CDSCO has received total of 22 applications for manufacturing and marketing of the drug Molnupiravir in the country
UAE approves Sinopharm’s protein-based vaccine
The vaccine will be produced and distributed by a joint venture between the UAE's Group 42 and China National Biotec Group (CNBG),…